Investors Cheating Themselves by Focusing on Largest ETFs | Benzinga

Investors Cheating Themselves by Focusing on Largest ETFs | Benzinga: The fund IBB is closest to in terms of performance, the SPDR S&P Biotech ETF (NYSE: XBI), has outpaced IBB by over 300 basis points. The First Trust NYSE Arca Biotech Index Fund (NYSE: FBT) has topped IBB by 660 basis points. A biotech ETF that rarely gets the credit it deserves, the Market Vectors Biotech ETF (NYSE: BBH), has jumped almost 58 percent this year in near stealth fashion.